Daniil Gataulin

Analyst-Equity chez Chardan Capital Markets LLC

Profil

Dr. Daniil Gataulin is a Senior Research Analyst at Chardan Capital Markets LLC.
Prior to Chardan, Dr. Gataulin held a Senior Research Associate position at Raymond James, where he covered SMID biotech companies with the focus on neurology, hematology, and gene therapy.
Prior to his role at Raymond James, Dr. Gataulin studied the mechanism of DNA repair and recombination in the laboratory of Dr. Doug Bishop at the University of Chicago, where he discovered a novel role for ATP hydrolysis by a DNA repair/recombination protein.
He holds a BS in Cell Molecular Biology from Grand Valley State University, Master’s degree in Biotechnology from Illinois Institute of Technology, and a PhD in Molecular Genetics and Cell Biology from the University of Chicago.

Postes actifs de Daniil Gataulin

Sociétés	Poste	Début
Chardan Capital Markets LLC	Analyst-Equity	01/07/2021

Anciens postes connus de Daniil Gataulin

Sociétés	Poste	Fin
Raymond James & Associates, Inc.	Analyst-Equity	01/07/2021